Lili Wu

Shijiazhuang, 050035, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A dual-mechanism model of Selinexor in DLBCL: p53 reactivation and metabolic reprogramming.

A dual-mechanism model of Selinexor in DLBCL: p53 reactivation and metabolic reprogramming.

Journal: Journal of translational medicine

Published: October 02, 2025

ATF6 and pS6K as prognostic biomarkers in newly diagnosed diffuse large B-cell lymphoma.

ATF6 and pS6K as prognostic biomarkers in newly diagnosed diffuse large B-cell lymphoma.

Journal: Scientific reports

Published: March 15, 2025

ATF6 activation promotes tumorigenesis and drug resistance in diffuse large B-cell lymphoma (DLBCL) by regulating the mTOR/S6K signaling pathway.

ATF6 activation promotes tumorigenesis and drug resistance in diffuse large B-cell lymphoma (DLBCL) by regulating the mTOR/S6K signaling pathway.

Journal: Discover oncology

Published: January 10, 2025

Activation of Notch-1 signaling pathway in macrophages to secrete PD-L1 and regulate cytotoxicity of CAR-T cells in diffuse large B-cell lymphoma.

Activation of Notch-1 signaling pathway in macrophages to secrete PD-L1 and regulate cytotoxicity of CAR-T cells in diffuse large B-cell lymphoma.

Journal: Aging

Published: May 12, 2023

Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells.

Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells.

Journal: BMC cancer

Published: May 13, 2022

Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis.

Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis.

Journal: Disease markers

Published: April 18, 2022

Challenges and strategies of clinical application of CAR-T therapy in the treatment of tumors-a narrative review.

Challenges and strategies of clinical application of CAR-T therapy in the treatment of tumors-a narrative review.

Journal: Annals of translational medicine

Published: November 04, 2020

Efficacy and safety of CD19 chimeric antigen receptor T cells in the treatment of 11 patients with relapsed/refractory B-cell lymphoma: a single-center study.

Efficacy and safety of CD19 chimeric antigen receptor T cells in the treatment of 11 patients with relapsed/refractory B-cell lymphoma: a single-center study.

Journal: Annals of translational medicine

Published: November 04, 2020

CircNPM1 strengthens Adriamycin resistance in acute myeloid leukemia by mediating the miR-345-5p/FZD5 pathway.

CircNPM1 strengthens Adriamycin resistance in acute myeloid leukemia by mediating the miR-345-5p/FZD5 pathway.

Journal: Central-European journal of immunology

Published: October 21, 2020

Primary Gastrointestinal Lymphoma: A Retrospective Multicenter Clinical Study of 415 Cases in Chinese Province of Guangdong and a Systematic Review Containing 5075 Chinese Patients.

Primary Gastrointestinal Lymphoma: A Retrospective Multicenter Clinical Study of 415 Cases in Chinese Province of Guangdong and a Systematic Review Containing 5075 Chinese Patients.

Journal: Medicine

Published: December 04, 2015

A functional polymorphism in microRNA-196a2 is associated with increased susceptibility to non-Hodgkin lymphoma.

A functional polymorphism in microRNA-196a2 is associated with increased susceptibility to non-Hodgkin lymphoma.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: October 15, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026